List of Excipients in API spironolactone and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing spironolactone and hydrochlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | ALDACTAZIDE | spironolactone and hydrochlorothiazide | 0025-1011 | CALCIUM SULFATE | |
| Pfizer Laboratories Div Pfizer Inc | ALDACTAZIDE | spironolactone and hydrochlorothiazide | 0025-1011 | FERRIC OXIDE RED | |
| Pfizer Laboratories Div Pfizer Inc | ALDACTAZIDE | spironolactone and hydrochlorothiazide | 0025-1011 | HYDROXYPROPYL CELLULOSE | |
| Pfizer Laboratories Div Pfizer Inc | ALDACTAZIDE | spironolactone and hydrochlorothiazide | 0025-1011 | HYPROMELLOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing spironolactone and hydrochlorothiazide
Detailed excipient profiles for spironolactone and hydrochlorothiazide
Excipient focus: ALUMINUM OXIDE
spironolactone and hydrochlorothiazide drug variants containing ALUMINUM OXIDE
spironolactone and hydrochlorothiazide drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS LACTOSE
spironolactone and hydrochlorothiazide drug variants containing ANHYDROUS LACTOSE
spironolactone and hydrochlorothiazide drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM SULFATE
spironolactone and hydrochlorothiazide drug variants containing CALCIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing CALCIUM SULFATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
spironolactone and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
spironolactone and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: D&C YELLOW NO. 10
spironolactone and hydrochlorothiazide drug variants containing D&C YELLOW NO. 10
spironolactone and hydrochlorothiazide drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
spironolactone and hydrochlorothiazide drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: DOCUSATE SODIUM
spironolactone and hydrochlorothiazide drug variants containing DOCUSATE SODIUM
spironolactone and hydrochlorothiazide drug variants not containing DOCUSATE SODIUM
Excipient focus: FD&C YELLOW NO. 6
spironolactone and hydrochlorothiazide drug variants containing FD&C YELLOW NO. 6
spironolactone and hydrochlorothiazide drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
spironolactone and hydrochlorothiazide drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing FERRIC OXIDE RED
Excipient focus: HYDROXYPROPYL CELLULOSE
spironolactone and hydrochlorothiazide drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
spironolactone and hydrochlorothiazide drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing HYPROMELLOSE
Excipient focus: LACTOSE
spironolactone and hydrochlorothiazide drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | spironolactone and hydrochlorothiazide | 54868-0699 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
spironolactone and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
spironolactone and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
spironolactone and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MENTHOL
spironolactone and hydrochlorothiazide drug variants containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| Physicians Total Care Inc | spironolactone and hydrochlorothiazide | 54868-0699 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing MENTHOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
spironolactone and hydrochlorothiazide drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: PEPPERMINT
spironolactone and hydrochlorothiazide drug variants containing PEPPERMINT
spironolactone and hydrochlorothiazide drug variants not containing PEPPERMINT
Excipient focus: PEPPERMINT OIL
spironolactone and hydrochlorothiazide drug variants containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| Physicians Total Care Inc | spironolactone and hydrochlorothiazide | 54868-0699 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing PEPPERMINT OIL
Excipient focus: POLYETHYLENE GLYCOL
spironolactone and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POVIDONE
spironolactone and hydrochlorothiazide drug variants containing POVIDONE
spironolactone and hydrochlorothiazide drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| Physicians Total Care Inc | spironolactone and hydrochlorothiazide | 54868-0699 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
spironolactone and hydrochlorothiazide drug variants containing SILICON DIOXIDE
spironolactone and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
spironolactone and hydrochlorothiazide drug variants containing SODIUM BENZOATE
spironolactone and hydrochlorothiazide drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM LAURYL SULFATE
spironolactone and hydrochlorothiazide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| Physicians Total Care Inc | spironolactone and hydrochlorothiazide | 54868-0699 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
spironolactone and hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
spironolactone and hydrochlorothiazide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
spironolactone and hydrochlorothiazide drug variants containing STARCH, CORN
spironolactone and hydrochlorothiazide drug variants not containing STARCH, CORN
Excipient focus: TITANIUM DIOXIDE
spironolactone and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
spironolactone and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
